According to a recent review, 67 recognized natural compounds have the ability to fight cancer’s resistance to EGFR-TKIs through at least 30 pathways, primarily ROS, PD-L1, EGFR, MAPK, mTOR, HSP90, JNK, PTEN, and FOXO [86]. This evidence concerns the gene CD274 and cancer.